🔎 Trials Near Me

Akèy › Dyabèt tip 1 › New York

Etid klinik pou Dyabèt tip 1 nan New York

23 etid pou Dyabèt tip 1 ap chèche patisipan nan sit nan New York.

Vil nan New York

Tèks ofisyèl etid la (Anglè)

App-Based Certified Diabetes Education Therapy (AB-CDE)

  • Mount Sinai School of Medicine, New York
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07282639

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  • University At Buffalo - Jacobs School Of Medicine- Site Number : 8400006, Buffalo
  • Endocrine Associates of West Village- Site Number : 8400064, New York
  • Columbia University Irving Medical Center- Site Number : 8400009, New York
Ap rekriteFaz 3
Laj 1 a 25 · Tout sèks · Mizajou Sep 14, 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • UBMD Pediatrics - University of Buffalo, Buffalo
  • Hassenfield Children's Hospital, New York
  • NYU Langone Diabetes & Endocrine Associates, New York
Ap rekriteFaz 1/2
Laj 12 a 35 · Tout sèks · Mizajou Sep 11, 2026 · NCT06783309

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

  • Columbia University, New York
Ap rekriteFaz 2
Laj 4 a 34 · Tout sèks · Mizajou Sep 9, 2026 · NCT07216391

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  • Columbia University, New York
Ap rekriteFaz 2
Laj 8 a 45 · Tout sèks · Mizajou Sep 8, 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  • University of Buffalo, Buffalo
Ap rekriteFaz 1/2
Laj 9 a 20 · Tout sèks · Mizajou Sep 2, 2026 · NCT07061574

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

  • SUNY Upstate Medical Center, Albany
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599982

HLA Demographics Study in Adults With Type 1 Diabetes

  • Icahn School of Medicine at Mount Sinai, New York
Ap rekriteEtid obsèvasyon
Laj 18 a 55 · Tout sèks · Mizajou Aug 28, 2026 · NCT06860516

Long-Term Outcomes of Teplizumab in Routine Clinical Care

  • Investigational Site Number: 8400001, New York
  • Investigational Site Number: 8400002, Syosset
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 25, 2026 · NCT07360080

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

  • University at Buffalo MD Physicians Group, Buffalo
Ap rekriteFaz 2
Laj 5 a 40 · Tout sèks · Mizajou Aug 24, 2026 · NCT07187531

APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life

  • Weill Cornell Medicine, New York
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 19, 2026 · NCT07773779

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Aug 10, 2026 · NCT06919354

Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

  • Circuit Clinical, Buffalo
Ap rekriteEtid obsèvasyon
Laj 2 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT06144554

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

  • Mount Sinai, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT07676565

Kidney Precision Medicine Project

  • Mount Sinai, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT04334707

Registry for Stage 2 Type 1 Diabetes

  • Women & Children's Hospital of Buffalo- Site Number : 8400018, Buffalo
  • Feinstein Institute for Medical Research (Northwell)- Site Number : 8400016, Manhasset
  • Ten's Medical PC- Site Number : 8400027, Staten Island
  • ak 1 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 13, 2026 · NCT06481904

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

  • Montefiore Einstein Medical Center, The Bronx
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Apr 1, 2026 · NCT06236607

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • SUNY Upstate Medical University, Syracuse
  • Albert Einstein College of Medicine / Montefiore Medical Center, The Bronx
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06217302

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

  • New York VA Hospital, New York
  • NYC Health + Hospitals/Bellevue, New York
  • NYU Langone Health, New York
  • ak 1 plis
Ap rekriteFaz 4
Laj 18 a 89 · Tout sèks · Mizajou Dec 29, 2025 · NCT05641753

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

  • Albert Einstein College of Medicine, The Bronx
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Oct 30, 2025 · NCT05734313

TrialNet Pathway to Prevention of T1D

  • Columbia University, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 45 · Tout sèks · Mizajou Jul 1, 2025 · NCT00097292

NYSCF Scientific Discovery Biobank

  • New York Stem Cell Foundation Research Institute, New York
Ap rekriteEtid obsèvasyon
30 Days · Tout sèks · Mizajou Mar 3, 2025 · NCT06203106

PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

  • Mt Sinai, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
0 Days – 99 Years · Tout sèks · Mizajou Nov 21, 2023 · NCT06141434

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.